NCT03627130View on ClinicalTrials.gov

The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

640

Participants

Timeline

Start Date

November 29, 2018

Primary Completion Date

May 30, 2022

Study Completion Date

May 30, 2022

Conditions
Contrast-induced NephropathyAcute Kidney InjuryAcute Coronary Syndrome
Interventions
DRUG

Potassium Nitrate

Potassium nitrate capsules (KNO3: 12 mmol giving 744 mg of nitrate) for 5 days

DRUG

Potassium Chloride

Potassium Chloride capsules for 5 days

Trial Locations (1)

EC1A 7BE

Barts Heart Centre, London

All Listed Sponsors
lead

Barts & The London NHS Trust

OTHER

NCT03627130 - The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy | Biotech Hunter | Biotech Hunter